Pseudomonas aeruginosa (Pa) and Aspergillus fumigatus (Af) are major human pathogens known to interact in a variety of disease settings, including airway infections in cystic fibrosis. We recently reported that clinical CF isolates of Pa inhibit the formation and growth of Af biofilms. Here, we report that the bacteriophage Pf4, produced by Pa, can inhibit the metabolic activity of Af biofilms. This phage-mediated inhibition was dose dependent, ablated by phage denaturation, and was more pronounced against preformed Af biofilm rather than biofilm formation. In contrast, planktonic conidial growth was unaffected. Two other phages, Pf1 and fd, did not inhibit Af, nor did supernatant from a Pa strain incapable of producing Pf4. Pf4, but not Pf1, attaches to Af hyphae in an avid and prolonged manner, suggesting that Pf4-mediated inhibition of Af may occur at the biofilm surface. We show that Pf4 binds iron, thus denying Af a crucial resource. Consistent with this, the inhibition of Af metabolism by Pf4 could be overcome with supplemental ferric iron, with preformed biofilm more resistant to reversal. To our knowledge, this is the first report of a bacterium producing a phage that inhibits the growth of a fungus and the first description of a phage behaving as an iron chelator in a biological system. †Present address:
INTRODUCTION
Cystic fibrosis (CF) is a genetic disease associated with viscous mucus, decreased mucociliary clearance and chronic airway infections (Rowe et al., 2005) . There is great interest in understanding the pulmonary microbial ecology in CF and its contributions to disease pathogenesis.
Pseudomonas aeruginosa (Pa) (Govan & Deretic, 1996; Høiby et al., 2010) and Aspergillus fumigatus (Af) (Amin et al., 2010; Baxter et al., 2013; Kaur & Singh, 2014) are the most common bacterium and fungus infecting airways in CF, respectively. Both organisms are associated with a more rapid decline in CF pulmonary function (Fillaux et al., 2012; Nicolai et al., 1990; Ramsey et al., 2014; Schønheyder et al., 1985; Shoseyov et al., 2006; Speirs et al., 2012) and can cause invasive disease (Cahill et al., 1997; Nunley et al., 1998; Yeldandi et al., 1995) or other complications (Botha et al., 2008; Garantziotis & Palmer, 2009; Stevens et al., 2003) .
Both organisms also contribute to mucus plug formation in the airways and are known to form biofilms (Costerton et al., 1999; Kaur & Singh, 2014) . These aggregates of microbes have polymeric matrices that promote adhesion and protect against both antibiotics and host immunity (Hall-Stoodley & Stoodley, 2009 ). Co-colonization of the lungs of CF patients with Pa and Af can result in more severe pulmonary disease. However, Pa can be inhibitory to Af through the production of multiple antimicrobials such as pyocyanin (5-N-methyl-1-hydroxyphenazine) (Blyth, 1971; Briard et al., 2015; Kerr et al., 1999; Mangan, 1969) , 1-hydroxyphenazine (Briard et al., 2015; Kerr et al., 1999; Mangan, 1969) , phenazine-1-carboxamide and phenazine-1-carboxylic acid (Briard et al., 2015) .
We have recently studied how clinical isolates of Pa inhibit the formation and growth of Af biofilms . Pa isolates from CF patients were more inhibitory towards Af than were non-CF isolates, and non-mucoid CF isolates were most inhibitory of all. Inhibition did not require Pa contact, as culture filtrates were also inhibitory. Inhibition of Af biofilms was dependent on bacterial growth conditions; culture filtrates from Pa biofilms were more inhibitory than those from planktonically grown Pa. We found that supplemental iron overcame the inhibitory effect of Pa supernatants on Af; moreover, denial of iron via chelation also inhibited Af . Although the relevant Pa factor(s) responsible for this inhibition was undefined, as has been the case in previous studies of nonbiofilm Af (Blyth, 1971; Kakizaki et al., 2004; Kerr et al., 1999; Mangan, 1969) , our studies indicated soluble Paderived molecules were responsible.
One factor produced in abundance by Pa biofilms is filamentous Pf bacteriophage belonging to the genus Inovirus (Webb et al., 2004) . These bacteriophage are long, negatively charged filaments,~2 µm in length and 6-7 nm in diameter. Pf phage are produced by CF clinical isolates (Finnan et al., 2004; Kirov et al., 2007; Manos et al., 2008; Mathee et al., 2008) including epidemic Pa strains (Winstanley et al., 2009) and viscous, anaerobic conditions, such as those that might be encountered at sites of infection, stimulate Pf phage production (Platt et al., 2008; Yeung et al., 2009) . With Pa phage in CF airways, along with Af, the possibility of a phage-fungus interaction was of interest. Here, we have tested the hypothesis that clinically relevant concentrations of filamentous Pf phage produced by Pa biofilms could also affect Af biofilm metabolism.
METHODS
Aspergillus fumigatus. Af was cultured as previously described . In brief, strain 10AF was grown on potato dextrose agar and incubated at 37 C for 3-4 days. Conidia were harvested by washing plates with sterile PBS (pH 7.4) (Lonza) with 0.05 % v/v Tween 80. The conidial suspension was diluted to 10 5 spores ml À1 in fresh RPMI-1640 medium (Lonza).
Phage preparation. Three phages, two from Pa (Pf1, Pf4) and one from Escherichia coli (fd), were studied. Pa strain K (PAK, ATCC 25102) produced Pf1 (ATCC 25102B) and Pa strain PAO1 produced Pf4. In particular, we used strain MPAO1, originating from the laboratory of Dr Colin Manoil (Jacobs et al., 2003) , which carries only the Pf4 prophage and not RPG42. As a control, a phage-deficient mutant was included in our experiments. This strain, PAO1 DPA0728, was created using the deletion construct pEX-DPA0728 (Castang & Dove, 2012) as described (Secor et al., 2015) by allelic exchange (Hmelo et al., 2015) . PAO1 DPA0728, is derived from strain PAO1 but lacks the phage integrase gene (PA0728) and is not able to maintain the replicative form of Pf4, although it can still be infected by Pf4 (Castang & Dove, 2012) . Deletion of PA0728 was confirmed by sequencing. All supernatants from DPA0728 were prepared and diluted in sterile PBS in the same way as phage samples. Phage were harvested as described previously (Boulanger, 2009) . In brief, bacteria were cultured in a 250 ml volume LB broth (Sigma-Aldrich) for 48 h at 37 o C, under shaking conditions. Bacteria were removed by centrifugation and the supernatant was sterilized by vacuum filtration through a 0.22 µm filter. Crude supernatant was treated with 1 µg ml À1 DNase (Sigma-Aldrich) for 2 h at 37 C. Phage were precipitated from the supernatant by adding 0.5 M NaCl and 10 % PEG 6000 (Sigma-Aldrich) and incubating the phage overnight at 4 C. Phage were then pelleted by centrifugation and the pellet suspended in sterile PBS and subjected to another round of PEG precipitation. Finally, a caesium chloride-based gradient purification was performed, after which the purified phage were suspended in sterile PBS, and dialysed in a 10 kDa cut-off cassette (Thermo Fisher Scientific) against PBS. The amounts of Pf1 and fd in suspensions were determined spectrophotometrically by measuring absorption, using the wavelengths and extinction coefficients as previously described (Zimmermann et al., 1986) . Pf4 was quantified by diluting the phage and plating on an indicator strain (DPA0728) to calculate plaque-forming units (Castang & Dove, 2012) . For control purposes, a second source of Pf4 was harvested from a Pa, grown as a biofilm. This harvested Pf4 was purified from the media, as described.
In vitro model of biofilm development. For all experiments examining Af biofilm formation, sterile polystyrene discs (Biosurface Technologies) were placed in 12-well tissue culture plates (Corning) containing 2.7 ml of fresh RPMI-1640 (Lonza) and 0.3 ml sterile PBS. The final conidia concentration in each well was 10 5 Af conidia ml À1 . Discs were incubated at 37 C for 16 h with shaking at 65-70 r.p.m. to allow the fungal cells to attach and form hyphae (biofilm formation phase). Following the formation phase, discs were On: Fri, 11 Jan 2019 13:38:10 rinsed gently in sterile saline (Baxter Healthcare) , transferred to new plates containing fresh RPMI-1640 medium and incubated for an additional 24 h at 37 C with shaking at 65-70 r.p.m. For preformed biofilms, discs were placed in 12-well tissue culture plates containing 3 ml of fresh RPMI-1640 and 10 5 Af conidia ml
À1
, and incubated for 16 h at 37 o C. After the initial 16 h, discs were gently rinsed in sterile saline, transferred to new plates containing 2.7 ml of fresh RPMI-1640 and 0.3 ml of sterile PBS and incubated for an additional 24 h at 37 C with shaking at 65-70 r.p.m.
Direct interaction of bacteriophage on Af biofilm formation. Af was allowed to form biofilms on the polystyrene discs in 12-well tissue culture plates containing 0.3 ml of phage in sterile PBS and 2.7 ml of RPMI-1640, which included 3Â10 5 Af conidia (final concentration of 10 5 conidia ml
). Final phage concentrations were 10 5 -10 9 phage ml
for Pf4, and 10 8 -10 10 phage ml À1 for fd or Pf1. Plates were then incubated at 37
C for 16 h with shaking at 65-70 r.p.m. The discs were then rinsed gently in sterile saline (Baxter Healthcare) , transferred to new plates with fresh RPMI-1640 and incubated for an additional 24 h at 37 C with shaking. Effects were evaluated by XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl-5[(phenylamino)carbonyl]-2H tetra-zolium hydroxide) assay .
Direct interaction of bacteriophage on preformed Af biofilm.
Fungal biofilms were formed as described above. After 16 h, the discs containing the fungal preformed biofilms were rinsed gently in sterile saline (Baxter Healthcare) , transferred to new plates containing 2.7 ml RPMI-1640 medium with 0.3 ml of phage in sterile PBS (final phage concentrations in each well: 10 5 -10 9 phage ml À1 , Pf4; 10 8 -10 10 phage ml À1 for fd and Pf1), prepared as described above, and incubated for an additional 24 h at 37 C with shaking at 65-70 r.p.m. Effects were evaluated by XTT assay.
Effect of Pf4 phage on planktonic Af. Af conidia were diluted in RPMI-1640 for susceptibility testing as per CLSI guidelines (Rex, 2008) , by broth macrodilution with continuous agitation. Phage (10 9 ) were diluted twofold as the test 'drug'. Fungal growth was quantified visually at 24 h and the standard 48 h incubation. In addition, the growth was assayed by the XTT method .
Reversal of Pf4 inhibition of Af biofilm formation and preformed biofilm with FeCl 3 . To examine whether Pf4 inhibition of Af biofilm formation is related to Af iron metabolism, we tested the activity of Pf4 against Af biofilm formation in the presence of FeCl 3 . To study biofilm formation, discs were prepared as described above. Each well contained 2.4 ml of fresh RPMI-1640 medium plus 0.3 ml of Pf4 or Pf1 phage (as a control) in PBS (pH 7.3 to 7.5) (Lonza) or PBS only (controls), with 0.3 ml of varying concentrations of FeCl 3 in RPMI-1640, or RPMI-1640 alone (controls). The phage concentrations for Pf4 and Pf1 were 10 9 phage ml
. The final concentrations of FeCl 3 were 10-fold dilutions from 30 mM to 300 µM, and threefold dilutions from 297 to 11 µM. Discs were incubated for 16 h at 37 C, to allow Af cells to form biofilm in the presence of phage ± FeCl 3 . After this initial 16 h, non-adherent cells were removed through washing with PBS, and the discs were transferred to 3 ml of fresh RPMI-1640 medium without phage for an additional 24 h of growth at 37 C, before quantification of fungal metabolism by the XTT assay. To examine whether Pf4 inhibition of preformed Af biofilm is due to Pf4 phage effects on Af iron metabolism, we tested Pf4 against preformed Af biofilm in the presence of FeCl 3 . Preformed biofilms were prepared as described above. After washing the biofilms at 16 h, 2.4 ml of RPMI-1640 medium plus 0.3 ml of Pf4 or Pf1 phage (as a control) in PBS (pH 7.3 to 7.5) or PBS only (controls) were added to the wells, with 0.3 ml of varying concentrations of FeCl 3 in RPMI-1640 or RPMI-1640 alone (controls). The phage and FeCl 3 concentrations were as described in this paragraph. After 40 h of incubation in total, an XTT assay was performed to measure biofilm metabolic activity. . The iron solution was then dialysed against buffer using an Amicon Ultra-0.5 Centrifugal Filter Unit with Ultracel-10 kDa membrane (EMD Millipore). Finally, the iron content in the solution was measured via a colorimetric assay where the iron formed a coloured complex (BioVision) . The images in Fig. 6 were acquired at 40Â using a Canon EOS Rebel T5i camera mounted on a Zeiss Primo Vert-inverted light microscope.
Raman spectroscopy. The Raman measurements were performed using backscattering geometry on phage and phage-iron mixed samples, dried in air on titanium foil. The illumination source was a 473 nm Cobalt BluesÔ continuous-wave diode-pumped solid-state laser brought to the sample by a Mitutoyo long-working distance objective (100Â, 0.7 NA). Laser power at sample was 1.08 mW, as measured by Coherent LaserCheckÔ. The spectra were recorded for 600 s or longer, until sufficient counts were accumulated. Raman spectra were acquired in 10 min sequential acquisitions with an Andor CCD peltier-cooled camera (as part of a NTEGRA Spectra system) with a 600 grating from solid samples. Each spectrum was monitored for signs of sample degradation and discarded if any were observed. Optical images of the sample were obtained through the same objective. Raman spectra were baseline corrected to account for fluorescent background.
Birefringence measurements. Af biofilms were imaged using the Rotopol imaging system, as previously described (Secor et al., 2015) , to quantify the birefringence of Af biofilms grown with and without phage. Briefly, a custom polarizing microscope was adapted with a stepper motor, rotating polarizer and circular analyser. The Rotopol software was used to compute birefringence (|sin d|), and mean values of |sin d| of each biofilm were computed (Geday et al., 2000) .
Confocal laser-scanning microscopy (CLSM). For this procedure, 1 mg of Pf4 or Pf1 phage was dissolved in 1 ml of 0.1 M sodium bicarbonate buffer (pH 8.3). While stirring the phage solution, 50 µl of 10 mg ml À1 Alexa Fluor 488 TFP (tetrafluorophenyl) ester (Life Technologies), dissolved in DMSO, was added. The reaction was incubated for 1 h at room temperature while in a continuously rotating apparatus. A PD-10 Sephadex G-25 Desalting Column (GE Healthcare) was equilibrated with PBS, and the conjugate was separated on the gel filtration column according to the manufacturer's instructions for gravity-based separation. The labelled phage conjugate was then quantified for Pf concentration using a qPCR method detailed previously (Secor et al., 2015) .
Staining of the fungal biofilms was achieved with Syto 62 (Invitrogen Molecular Probes), 10 mM stock in 1 ml PBS, three drops added to the top of the biofilm at the end of the incubation periods to be described, which produces a red fluorescence of hyphae and extracellular matrix, with the filters used. Af biofilms were formed on discs as described above, and before microscopy were washed, mounted on glass slides, covered with a glass coverslip and maintained for 30 min at room temperature in the dark.
During the time periods studied, addition of labelled phage was made at the outset of the 16-h biofilm-formation step, then images taken (a) after the 16 h period, or (b) after allowing the biofilm to evolve during the second, 24-h period, taken at the end of the 40 h. Alternatively, phage were added only after biofilm formation at 16 h, and images taken IP: 54.70.40.11
On: Fri, 11 Jan 2019 13:38:10 24 h later. Finally, phage were added 2 h before the end of the 40 h period, and images taken 2 h later.
Sections on the x-y plane were taken at 1 µm intervals along the z-axis to determine the structure and depth of the biofilms. Microscopic visualization and image acquisition of biofilms were conducted at the Stanford Biofilm Research Center, using an upright Leica TCDSP2 scanning confocal laser microscope (Leica Lasertechnik) equipped with an argon/ krypton laser and detectors, and filter sets for monitoring of green (excitation 480 nm, emission 517 nm) and red (excitation 633 nm, emission 676 nm). Images were obtained using a 63Â1.4 Plan-APOChromat DIC (Leica) objectives. Multichannel simulated fluorescence projection (a shadow projection) images and vertical cross sections through the biofilm were generated using the IMARIS software package (Bitplane). Images were processed for display by using Photoshop software (Adobe). Representative images were taken.
Small-scale preparation of single-stranded Pf bacteriophage DNA. Solution of PEG-purified Pf4 phage was mixed 2 : 1 with phenol/ chloroform solution and vortex mixed twice for 30 s. The sample was centrifuged at 12 000 g for 1 min at room temperature, and the upper, aqueous layer was transferred to a new tube. This solution was added 2 : 1 to a 25 : 1 mixture of absolute ethanol/3 M sodium acetate (pH 5.2), vortex mixed and stored for 15 min at room temperature. After centrifugation at 12 000 g for 10 min at 4 C, supernatant was removed completely and the pellet washed in 70 % ethanol. After removing the ethanol through centrifugation at 12 000 g for 10 min at 4 C, the tube was air dried for 10 min and the pellet was dissolved in TE buffer (containing Tris and EDTA, pH 8.0). Concentration of ssDNA was measured with a nanodrop.
ssDNA was tested at concentrations matching the amount that would be present in corresponding amounts of phage per millilitre. For example, the columns that indicate 10 10 contain the amount of DNA that 10 10 phage ml À1 would have. This was calculated by taking the sequence of the Pf4-phage DNA, calculating its molecular weight and then calculating the mass of DNA that 10 10 phage would contain. 10 10 copies of phage DNA weigh 64.17 ng. The stock solution, which has a concentration of 385 ng µl
, was diluted to 650 ng ml À1 (10 11 copies ml
). Serial dilutions down to 10 8 copies ml À1 were made from this 10 11 copies ml À1 solution.
Culture of Af biofilms for birefringence measurements. Af strain 10AF was recovered from À80 C storage, inoculated on potato dextrose agar plates and incubated at 37 C for 4 days. Conidia were harvested by flooding the surface of the agar plates with 10 ml saline containing 0.05 % (v/v) Tween 80. The conidial suspension was adjusted to a transmittance of 50-52 % at 530 nm with fresh RPMI-1640, corresponding to 10 7 conidia ml
. The suspension was diluted further to 2Â10 4 conidia ml À1 as the working suspension. Sixteen-well sterile chamber slides with covers (Thermo Fisher Scientific-178599) were used for development of Af biofilm. We pipetted 100 µl of the working suspension of conidia into each well (2Â10 3 conidia/well) along with 100 µl fresh RPMI-1640. The chamber slides were incubated for 16 h at 37 C at 65 r.p.m. on a gyratory shaker to allow the fungi to form biofilm. After 16 h of biofilm formation, the medium was aspirated and the wells washed gently three times with 200 µl sterile PBS. After the addition of 200 µl of fresh RPMI to each well, the slides were incubated for an additional 22 h at 37 C at 65 r.p.m. on a gyratory shaker. After a total of 38 h of incubation, the medium in wells was replaced with 200 µl fresh RPMI-1640 with and without Pf1 or Pf4 bacteriophage (at 10 10 p.f.u. ml À1 ); Af biofilm without phage served as a control. After an additional 2 h incubation at 37 C at 65 r.p.m. on a shaker, the medium was aspirated from each well and 100 µl paraformaldehyde (4 % w/v) (SigmaAldrich-158127) was pipetted into each well and slides were held at room temperature overnight. The paraformaldehyde in wells was replaced with 100 µl distilled water.
Heat treatment. A phage suspension containing 10 9 phage ml À1 of Pf4 was placed in a 56 C water bath and heated for 30 min. Af conidia were exposed to Pf4 phage or heat-treated (HT) Pf4 phage for 16 h. Af preformed biofilms were exposed to Pf4 phage or HT Pf4, for 24 h. SEM preparation. Af biofilms were prepared as described above, and removed from growth media at appropriate time intervals, which were a total of 40 h after starting the experiments with Pf1 or Pf4 infection. For SEM processing, discs and biofilm mats were harvested and washed in situ twice with 100 ml of PBS to remove planktonic cells. Samples were fixed in 4 % paraformaldehyde with 2 % glutaraldehyde in 0.1 M sodium cacodylate buffer for 45 min. Samples were then briefly rinsed in the same buffer before post-staining with 1 % OsO 4 for 45 min. OsO 4 treated samples were rinsed in water and gradually dehydrated in increasing concentrations of ethanol (50, 70, 90, 100, 100 %, 5 min each). Samples were then critically point dried with liquid CO 2 using a Tousimis Autosamdri 815A and 15 min purge time (Tousimis). Dried samples were sputter coated (50 Å, Au/Pd) before imaging with a Zeiss Sigma FESEM using InLens SE detection at 2 kV operating voltage (Carl Zeiss Microscopy).
Statistical analyses. Where n is not stated, each experiment was performed at least two times, with triplicate wells each time. Data from experiments using XTT were analysed using one-way ANOVA with a Tukey's post-test. All statistical analyses were performed using GraphPad Prism (GraphPad Software). Statistical significance was considered P<0.05.
RESULTS
Clinically relevant concentrations of Pf4 phage inhibit Af metabolism in biofilm formation or preformed biofilm
To test whether filamentous bacteriophage inhibit Af metabolism, we added purified Pf4 to Af conidia prior to biofilm formation or to preformed biofilms and assessed metabolism using an XTT reduction assay. Schematics of these protocols are shown in Fig. S1a , b (available in the online Supplementary Material).
We found that Pf4 bacteriophage, purified from planktonically grown Pa strain PAO1, inhibited the metabolic activity of Af biofilms (P<0.001). All concentrations of Pf4 phage greater than 10 7 phage ml À1 inhibited the metabolic activity of Af conidia-forming biofilm (Fig. 1a) , while concentrations greater than 10 6 phage ml À1 inhibited the metabolic activity of preformed Af biofilms (P<0.001 for both comparisons) (Fig. 1b) . The inhibition of biofilm formation occurred in a concentration-dependent manner; concentrations of 10 7 inhibited more than lower concentrations (P<0.001), and 10 8 and 10 9 more than 10 7 (P<0.001). Likewise, inhibition of preformed biofilm was concentration dependent, e.g. 10 6 greater than 10 5 (P<0.001), 10 9 greater than 10 7 or 10 8 (P<0.001). The presence of 10 % FBS did not significantly impact the effect Pf4 phage on Af biofilm formation and on preformed Af biofilm.
To test whether Pf phage were indeed necessary for this effect, we generated a control, 'mock' phage preparation, from supernatants collected from a Pa strain lacking the Pf phage integrase (DPA0728) (Figs 1c and S2) , a gene essential for Pf4 production (Castang & Dove, 2012) . This mock phage preparation was prepared in the same way as purified Pf4 phage and titrated into Af cultures in identical volumes. This mock phage preparation only inhibited Af biofilms at the most concentrated preparations (Fig. 1d, e) .
These data indicate a decisive role for Pf4 in suppression of Af metabolism. However, they also indicate that trace impurities in our phage preparations at high concentrations also have inhibitory effects on Af metabolism. This is perhaps consistent with the existence of other molecules produced by Pa that inhibit Af (Blyth, 1971; Briard et al., 2015; Kerr et al., 1999; Mangan, 1969) .
The concentrations of Pf phage needed to inhibit Af metabolism are within the range of phage production spontaneously produced by clinical isolates of Pa. We recently reported that sputum collected from CF patients contained on average 10 7 Pf phage ml À1 (Secor et al., 2015) . Similarly, Pa biofilms produce, on average, 10 9 Pf phage ml
À1
, whereas planktonic isolates produce 10 5 Pf phage ml À1 (Fig. 1f) .
In contrast to the inhibition of fungal biofilms by Pf4, no inhibition of fungal growth was observed at 24 or 48 h in broth macrodilution when a conidial inoculum produced planktonic Af growth (6.3Â10 7 to 1Â10 9 Pf4 phage tested), nor was any inhibition demonstrated by XTT testing of the growth.
Pf1 and fd phage do not inhibit Af biofilm metabolism
To assess whether the inhibitory capacity of Pf4 phage on Af biofilm was specific to Pf4 phage, we tested other filamentous bacteriophage, namely E. coli-derived fd phage and another Pa phage, Pf1, against Af-forming biofilm and preformed Af biofilm under the same conditions as tested using Pf4. Unlike Pf4, fd phage did not inhibit the metabolic activity of Af biofilms (Fig. 2a, b) . Likewise, Pf1 phage demonstrated no inhibition of Af biofilms (Fig. 2c, d ). . Pf4 phage purified from PAO1 was added to Af cultures. After the 40 cumulative hours of growth, biofilm metabolic activity was quantified by assessing the oxidative reduction of XTT absorbance at 490 nm. Pf4 was added (a) during Af BF formation (at the outset of 16 h culture of conidia on discs) or (b) to preformed Af BF (after 16 h of culture). Supernatant from a PAO1 strain incapable of producing phage (DPA0728) underwent the same phage-purification protocols and the resulting material we have is called a 'mock' phage preparation. (c) The mock preparation purified from DPA0728 was devoid of Pf4, as indicated by SDS-PAGE. The mock phage preparation was incorporated into assays of (d) BF formation or (e) preformed Af BF. (f) Pf phage production by planktonic and biofilm cultures of Pa. A single asterisk denotes a significant P value (<0.05), and three asterisks denote a significant P value (<0.001) compared with controls (in (f), *** means comparison with planktonic).
HT Pf4 and ssDNA isolated from Pf4 do not inhibit Af metabolism
whether or not the phage DNA are part of the mechanism behind the inhibition of the Af by Pf4, we tested the effects of single-stranded phage DNA on the formation and further development of Af biofilm. ssDNA was tested at concentrations matching the amount that would be present in corresponding amounts of phage per millilitre. This approach is further described in Methods. ssDNA was added 1 : 10 to the wells of the 12-well plates that contained Af-forming biofilm or preformed Af biofilm. Thus, final concentrations of ssDNA in each well ranged from 10 10 to 10 7 copies ml
À1
. Using these methods, we found that purified ssDNA from Pf4 phage alone did not inhibit Af metabolism (data not shown). Af biofilm (after 16 h of culture). Pf1 phage were added at the indicated concentration (c) during Af biofilm formation or (d) to preformed Af biofilm. HT phage were added at the indicated concentration to (e) Af conidia at the outset of 16 h biofilm formation or (f) at 16 h, preformed Af BF. In all cases, after the 40 cumulative hours of culture, biofilm metabolic activity was quantified by assessing the oxidative reduction of XTT absorbance at 490 nm. Three asterisks denote a significant P value (<0.001) compared with the Af-only control (AF in figures). Three daggers denote P<0.001 for comparisons with Af + fd or Af + Pf1. Two asterisks or two daggers denote P<0.01.
Given that ssDNA from Pf4 was not sufficient to inhibit Af, we asked whether intact phage were sufficient. To this end, we heat treated Pf4 phage (30 min at 56 C) and added this to Af biofilms. Compared with controls, HT Pf4 phage added at 10 9 phage ml
, a concentration where untreated Pf4 phage were inhibitory, did not inhibit the oxidative metabolism of Af biofilms (P<0.001) (Fig. 2e, f) .
Pf4 binds to Af biofilms
To examine the physical interaction of the bacteriophage with the Af, Alexa Fluor 488-labelled bacteriophage were added to Af biofilms and imaged by CLSM. We then made images at the end of the 16 h (biofilm formation) + 24 h (extension of preformed biofilm) periods (40 h total). This now showed extensive coating of Af by Pf4, not only of hyphae, but also of extracellular matrix in the Pf4 co-cultures. In contrast, no coating of Af biofilm by Pf1 was apparent after such interval (Fig. 3a, b) . The earliest images in the cycle were those at 16 h, the end of the biofilm formation period, when the labelled phage had been added at the outset. The Pf4 images showed uniform staining of hyphae (Pf4 labelled green). In contrast, the Pf1 images showed spotty and streaky coating of Pf1 along hyphae (Fig. 3c, d ).
To address questions about the stability of the two phage preparations, and how long phage binding lasted, we performed studies where phage were added after the 16 h period and images taken 24 h later, or added at 22 h during the 24-h preformed biofilm-culture period, with images taken 2 h after adding phage. The former showed Pf4 again staining both hyphae and extracellular matrix (Fig. 3f) , as did the latter 2 h period (Fig. 3h) . The hyphal staining by Pf1 was again streaky with the 24 h co-culture (Fig. 3e) , and the 2 h co-culture study showed the Pf1 preparation was intact because it would stain hyphae, more robustly, in the short term (Fig. 3g) .
Measures of the biofilm depth showed some thinning of the biofilm after the 40 h treatment with Pf4, compared with no treatment (controls) or Pf1 treatment, but the differences were not statistically significant (data not shown).
Filamentous phage, like Pf4, spontaneously align with each other when their concentrations are sufficiently high. This alignment can be quantified by measuring birefringence, an optical property directly affected by the molecular alignment of the sample, as we reported previously (Secor et al., 2015) . Birefringence measurements of Af biofilms revealed that the Pf4 coating Af increased the birefringence of these biofilms (Fig. 3i-u) . Pf1 on the other hand, did not significantly increase the birefringence of Af biofilms. These data are shown for individual hyphae (Fig. 3i-o) as well as for entire visual fields of mycelium (Fig. 3p-v) . Together with the confocal results, these data suggest that Pf4 thoroughly coats Af, so much so that it alters the polarization of light.
While both phages do adhere to hyphae quickly, this effect is more extensive and longer lasting with Pf4.
SEM studies
To further characterize the physical interaction of the bacteriophage with Af, Pf1 or Pf4 phages were added to Af biofilms and processed for SEM imaging at the end of the 40 h periods, i.e. 16 h (biofilm formation) + 24 h (extension of preformed biofilm), and 38 h (preformed biofilm) + 2 h (extension). Although Pf1 did not noticeably interact with Af (Fig. 4a) , Pf4 phage showed extensive ultrastructural impact on Af, not only of hyphae but also of extracellular matrix (Fig. 4b-d) . In particular, when Pf4 was added at 38 h, i.e. after 2 h of Pf4-associated interaction with Af, individually attached bacteriophage (Pf4) was visible at ultrahigh magnification (see Fig. 4d ). When Pf4 was associated with Af for extended times (Fig. 4b, c) , sheets of fibrous ECM (extracellular matrix)-like material formed a conspicuous interconnecting network between hyphae.
Supplemental iron overcomes Pf4-mediated inhibition of Af metabolism
We recently reported that phage can sequester cationic antibiotics (Secor et al., 2015) and filamentous bacteriophage are known to bind a variety of multivalent cations with high affinity (Janmey et al., 2014; Tang et al., 2002) , and that iron chelation can inhibit Af biofilm . Therefore, we wondered whether the mechanism by which Pf4 inhibits Af could be via binding of iron.
We first examined the effect of Pf phage and iron on biofilm formation. Pf4 or Pf1 phages were added to conidia for the 16 h incubation. Ferric iron (FeCl 3 ) was added to various phage co-cultures at threefold increasing concentrations from 11 to 297 µM, then 10-fold increasing concentrations from 300 µM to 30 mM, and compared, after washing at 16 h and additional 24 h culture, with the usual control (Af without phage, or iron). Pf4 alone inhibited Af (P<0.001) whereas Pf1 did not. Concentrations of FeCl 3 from 11 to 297 µM resulted in loss of inhibition by Pf4. Concentrations of 300 µM to 30 mM FeCl 3 enhanced Af biofilm formation, despite Pf4 (Fig. 5a) .
A similar experiment was performed by adding phage and iron to preformed Af biofilm, only after the 16 h formation period and wash. After 24 h of co-culture, Pf4 alone again inhibited (P<0.001), and Pf1 did not. Concentrations of FeCl 3 from 11 to 99 µM did not affect Pf4 inhibition; 297 and 300 µM reduced Pf4 inhibition, though the inhibition was still significant, 3000 µM ablated the inhibition, and 30 mM enhanced Af biofilm formation despite Pf4 (Fig. 5b) .
Pf4 bacteriophage bind iron
Given the data in Fig. 5 , we asked whether Pf4 could bind Fe 3+ . We found that mixtures of Pf4 and FeCl 3 rapidly formed a dense, gel-like structure and came out of solution IP: 54.70.40.11
On: Fri, 11 Jan 2019 13:38:10 ( Fig. 6a-e) . This is consistent with the crosslinking observed between filamentous phages and other multivalent cations (Janmey et al., 2014; Tang et al., 2002) . This effect was far less pronounced with Pf1 (Fig. 6d) .
We then developed a simple binding assay that used a semipermeable membrane of a size that allows Fe 3+ but not Pf4 across. By adding Pf4, Pf1 or buffer to the same side of the membrane to which we added Fe 3+ , we could measure the free Fe 3+ that flowed to the other side and calculate the binding fraction. Of the free Fe 3+ , approximately 30 % is bound by Pf4 phage, or~65 µM of a starting concentration of 200 µM. This difference is significant (P=0.001) (Fig. 6f) . Pf1 also bound Fe 3+ (P=0.005) but significantly less than Pf4 (P = 0.015) (Fig. 6f) .
We then examined phage interactions with Fe 3+ on a molecular scale using Raman spectrometry. We found that the signal from amide groups on Pf4 was reduced, indicating that these structures were constrained, and that Pf4 and Fe 3+ directly interact (Fig. 6g) . Conversely, this relationship was not seen with Pf1 (Fig. 6h) . These findings are shown for multiple different points of analyses (Fig. 6i) . These data suggest that Pf4 and Pf1 interact in distinct, non-equivalent ways with Fe 3+ , and that these different interactions may underlie the differences in Fe 3+ binding efficiency observed in Fig. 6(f) .
DISCUSSION
We report that a bacteriophage, Pf4, produced by Pa inhibits Af biofilms. The concentration of phage required for this effect was in the range of those produced by Pa in culture, or found in the lungs of patients with CF (Secor et al., 2015) . This phage-mediated inhibition is a novel mechanism by which Pa could restrict the formation and further development of Af biofilm.
Our work suggests that denial of Fe 3+ to Af by Pf4 is an important part of the Pf4 inhibition of Af. Iron concentrations are known to impact the severity of CF lung infections and Fe 3+ is a critical resource for Af . We found that supplemental iron could overcome Pf4-mediated inhibition of Af metabolism and we have demonstrated that Pf4 binds iron.
The finding that phage inhibition of Af relies on an irondependent mechanism is consistent with our previous finding that supplemental iron also overcame the inhibition seen with Pa supernatants .
We chose to measure Af inhibition by the XTT assay of metabolism because of the controversies in interpreting c.f.u. reduction in a multinucleate filamentous organism in a biofilm network (Clemons & Stevens, 2009; Singh et al., 2005) . However, others have shown that Pa is lethal to Af . Af biofilms' metabolic activity were quantified after 40 h total culture via XTT assay with absorbance at 490 nm. Assays were performed in triplicate in two different experiments (n=6). One asterisk indicates a P value <0.05, and two asterisks indicate a P value<0.001 for the XTT readings compared with the untreated control (AF in figures). (a) The effect of FeCl 3 on the inhibition of Af biofilm formation by Pf4 phage. Conidia were allowed to form biofilms for 16 h in the presence of Pf4, Pf1 and Pf4 + varying concentrations of FeCl 3 (concentrations shown in micromole or millimole). Biofilms were then washed and transferred to fresh RPMI-1640 for 24 h further growth. (b) The effect of FeCl 3 on the inhibition of Af-preformed biofilm by Pf4 phage. The 16-h-old, preformed Af biofilms were exposed to Pf4, Pf1 and Pf4 + varying concentrations of FeCl 3 (concentrations shown in micromole or millimole) for 24 h. (Manavathu et al., 2014) . Moreover, we also reported that the inhibitory effects of Pa supernatants on Af extended to measurements of biofilm thickness .
The phage findings do not exclude other mechanisms that Pa uses to inhibit Af. Pa are known to produce multiple molecules that are inhibitory to Af (Blyth, 1971; Briard et al., 2015; Kerr et al., 1999; Mangan, 1969) . Indeed, in a previous study of ours on the effect of supernatants of other Pa isolates on Af biofilm formation , the effect of phage was excluded by studies of a 30 000 MW filtrate, and Af inhibition was reversed by an iron concentration between 300 and 3000 µM. In the present paper, the inhibition of Af biofilm formation by phage was reversed by between 11 and 33 µM iron. Thus, the Af inhibition by phage appears more sensitive to iron inhibition than does iron inhibition by, collectively, the other elements in Pa supernatants. This may suggest that phage interference with iron metabolism of Af is weaker, relative to all the rest of the iron-limiting molecules collectively, produced by Pa strains, such as pyoverdine and pyochelin. However, the apparent binding of phage to Af structures could amplify the iron denial by phage. Moreover, an interaction with respect to inhibition between phage and other inhibitory factors is possible, and we are exploring that presently. Consistent with our hypothesis that Pf phage sequester iron from Af biofilms, the structural integrity of Pf4 was integral to its inhibitory effects on Af. Heat treatment of phage resulted in a loss of its inhibitory activity.
It is striking that Pf4 inhibited Af biofilm metabolism, but not planktonic conidial growth, and inhibited preformed biofilm more than biofilm formation. This would suggest the locus of phage action is something specific for hyphae or extracellular matrix (Reichhardt et al., 2015) . Consistent with this, our birefringence measurements and confocal microscopy studies indicate that Pf4 forms an ordered layer on Af biofilms. Our recent report that filamentous phage form complex interactions with polymers raises the possibility that Af biofilms may produce polymers that interact with phage and form into higher order structures. We propose that these structures and Pf4 binding to hyphae may impact the efficiency of iron sequestration and/or availability of iron to Af biofilms. Of note, the ability of Pf phage to bind cations is not limited to iron. We, and others, have previously shown that these and related phage interact with a diverse set of metals and cations on a charge basis and cause aggregation of phage (Janmey et al., 2014; Secor et al., 2015; Tang et al., 2002) . Moreover, multivalent cations cause more aggregation than monovalent cations (Tang et al., 2002) and trivalent cations are particularly effective (Janmey et al., 2014) . Although our efforts have focused on iron, given the critical nature of this for Af growth, these data do not preclude roles for these phage in binding other cations.
Inhibition of Af biofilm metabolic activity is limited thus far to a specific strain of Pa phage. Inhibition of Af metabolism was not seen with other filamentous phages tested, including fd, from E. coli, and Pf1, from Pa strain PAK. Our Raman-spectrometry studies indicating that Pf4 binds iron more efficiently than Pf1 are perhaps consistent with this. Some of this Pf4-Pf1 difference may perhaps reflect the greater length and proportionately increased charge area of Pf4 (Rakonjac et al., 2011) . However, Pf1 still binds some iron and it is of interest why this did not result in greater Af inhibition. The fact that the shorter Pf1 phage did not bind as extensively to Af biofilms may also help explain the less efficient inhibition of Af associated with this phage.
